The Institute of Microbiology at the Chinese Academy of Sciences (IMCAS) announced that its application for fully human monoclonal antibody clinical trials targeting COVID-19 has been approved by China’s drug regulatory authority called the National Medical Produts...
Chinese Academy of Sciences
Category
The New Chinese Alzheimer’s Drug (GV-971) Making its Way to Global Trials: Material Science or Marketing?
Is the world ready for GV-971(Oligomannate)? Because the first new approved Alzheimer’s drug in many years is coming to a clinical trial near you. Conditionally approved by China’s regulators, many in the West are skeptical. However, industry sponsor Green Valley...
Chinese Academy of Sciences (CAS) & Shanghai SIMR Biotechnology Co. Conduct Clinical Trial for Pain Drug SR419
A drug called SR419, developed by the Chinese Academy of Sciences (CAS) and Shanghai SIMR Biotechnology Co., Ltd. has entered clinical trials in China, reports the Ministry of Science and Technology. Reported in Xinhuanet, the pain reliever was developed to address...